VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 624 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,553 | -3.9% | 355,000 | +7.5% | 0.12% | +33.7% |
Q2 2023 | $9,940 | +375.1% | 330,124 | +410.5% | 0.09% | +411.1% |
Q1 2023 | $2,092 | -99.9% | 64,673 | -15.5% | 0.02% | +5.9% |
Q1 2022 | $2,936,000 | +25.6% | 76,568 | +4.9% | 0.02% | +54.5% |
Q4 2021 | $2,338,000 | -35.9% | 73,001 | -42.1% | 0.01% | -50.0% |
Q3 2021 | $3,646,000 | +445.0% | 126,101 | +578.7% | 0.02% | +266.7% |
Q4 2020 | $669,000 | -90.9% | 18,580 | -90.7% | 0.01% | -91.5% |
Q3 2020 | $7,333,000 | 0.0% | 199,911 | 0.0% | 0.07% | -34.3% |
Q2 2020 | $7,333,000 | +84.0% | 199,911 | +14.4% | 0.11% | -71.6% |
Q1 2017 | $3,985,000 | – | 174,687 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |